Brought to you by 
Endo Pharma licenses EpiCept's LidoPAIN, patents; rights later returned
09 Jul 2015
Executive Summary
Endo Pharmaceuticals (pain management products) has received an exclusive worldwide license to certain EpiCept (topical delivery of pain medications) patents and its LidoPAIN BP therapeutic.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Co-Promotion
- Includes Contract
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Endo Pharma licenses EpiCept's LidoPAIN, patents; rights later returned
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice